MisterBlues schreef op 8 oktober 2020 12:23:Een geheugenopfrissertje hoe goed Relief is:
The RLF100 story is simple...
Great drug with over 20,000 administrations. Safe, cheap, effective.
Targets CV19 via three pronged approach that beats all other drugs:
1) antiviral - surfactant protects ACE2 receptor and virus eventually dies
2) Immunomodulator (direct quote from Dr. J.). Decreases cytokine storm and thus, potentially long-haulers. Regulates deadly cytokines keeping at bay cytokine storm and does so broad spectrum unlike monoclonal antibodies that are specific.
3) Vasodilator/O2 transfer - increases Oxygen to the blood stream where the body needs it which is particularly important for CV19 patients.
4)-increases surfactant production (very, VERY important distinction from most other therapies)
5) stops apoptosis (cellular death, specifically Type-II Pneumocytes)
6) Cheapest drug in the pipeline.
7) “Miracle” statistically significant results in difficult 19/21 patients. While not double blinded, double blinded results are weeks away from DSMC review.
8) Covid-19 is going to be a problem for quite sometime creating 100’s of millions worldwide with the need for treatment.
9) Vaccine is questionable at best. With over 50% saying they won’t take it.
10) Gold Standard management team with deep connections.
11) Fully funded - no dilution anticipated for foreseeable future.
12) First in with EUA APPLICATION that can be awarded any day.
This is a buy and hold stock that will create 500%-3000% return.